The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease
about
Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study.Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis.Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data.3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.Metabolic effects of mulberry leaves: exploring potential benefits in type 2 diabetes and hyperuricemia.Integration of Traditional and Metabolomics Biomarkers Identifies Prognostic Metabolites for Predicting Responsiveness to Nutritional Intervention against Oxidative Stress and Inflammation.Uric acid: a starring role in the intricate scenario of metabolic syndrome with cardio-renal damage?Potential cow milk xanthine oxidase inhibitory and antioxidant activity of selected phenolic acid derivatives.Aldehyde and xanthine oxidase activities in tissues of streptozotocin-induced diabetic rats: effects of vitamin E and selenium supplementation.A new sensitive and quantitative chemiluminescent assay to monitor intracellular xanthine oxidase activity for rapid screening of inhibitors in living endothelial cells.A meta-analysis of the efficacy of allopurinol in reducing the incidence of myocardial infarction following coronary artery bypass grafting.Xanthine Oxidase: Isolation, Assays of Activity, and Inhibition
P2860
Q33643436-7D354617-21C8-4B60-9904-569E74768F9CQ34629589-662C21F2-7451-4F63-A34E-8D72E6FACD7EQ36317644-AC27FBE3-E0FB-4264-8B1E-2617EAED3A0FQ37277498-4F1B275C-5A95-4B11-9840-E4339621A0A9Q37408029-48941059-66EC-44AC-8AC2-2DFC2D37F69DQ37729705-CBCF1BB2-960B-46A0-9371-173442F8CD41Q37917648-73612485-910F-43B4-B34A-440E7FF6EEC0Q48126016-BA6603CE-763C-44D1-B556-0112423F4C9FQ51362753-6E870C15-1006-405F-AB6C-4C4E05844C92Q53064592-EFF69884-8551-4024-A0B1-6D065F05349CQ55619193-688D1AED-A6E2-4FAB-BE68-04A69711FD76Q59111633-0655A68B-9619-43AB-BEF0-A359F9A4F361
P2860
The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The potential for xanthine oxi ...... ar and cerebrovascular disease
@ast
The potential for xanthine oxi ...... ar and cerebrovascular disease
@en
The potential for xanthine oxi ...... ar and cerebrovascular disease
@en-gb
The potential for xanthine oxi ...... ar and cerebrovascular disease
@nl
type
label
The potential for xanthine oxi ...... ar and cerebrovascular disease
@ast
The potential for xanthine oxi ...... ar and cerebrovascular disease
@en
The potential for xanthine oxi ...... ar and cerebrovascular disease
@en-gb
The potential for xanthine oxi ...... ar and cerebrovascular disease
@nl
altLabel
The Potential for Xanthine Oxi ...... ar and Cerebrovascular Disease
@en
prefLabel
The potential for xanthine oxi ...... ar and cerebrovascular disease
@ast
The potential for xanthine oxi ...... ar and cerebrovascular disease
@en
The potential for xanthine oxi ...... ar and cerebrovascular disease
@en-gb
The potential for xanthine oxi ...... ar and cerebrovascular disease
@nl
P2093
P2860
P356
P1476
The potential for xanthine oxi ...... ar and cerebrovascular disease
@en
P2093
Jesse Dawson
Matthew Walters
Peter Higgins
P2860
P304
P356
10.1155/2009/282059
P407
P577
2009-01-01T00:00:00Z